Washington, DC 6/28/12—In a filing with the SEC, Thermo Fisher Scientific disclosed that it is seeking to sell its laboratory workstations business, which is part of its Laboratory Products and Services segment, in order to exit noncore businesses. The workstations business had 2011 sales of $180 million and an operating loss of $6 million, which is net of $4 million in restructuring costs. The company plans to record an after-tax charge of $50 million in the second quarter as an estimated loss on the divestment. The sale is expected to be completed by year end.